A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
Incyte Corporation
Formation Biologics
Numab Therapeutics AG
Novartis
Genmab
Nektar Therapeutics
Calithera Biosciences, Inc
Incyte Corporation
Novartis
Incyte Corporation
Eli Lilly and Company
Incyte Corporation
Ipsen
Merrimack Pharmaceuticals